SYNTHESIS OF POTENTIAL ANTI-INFLAMMATORY PYRAZOLINE DERIVATIVES UNDER ULTRASONIC IRRADIATION
HTML Full TextSYNTHESIS OF POTENTIAL ANTI-INFLAMMATORY PYRAZOLINE DERIVATIVES UNDER ULTRASONIC IRRADIATION
J. P. Sethiya 1, S. P. Bhavsar 2 and H. V. Shahare * 2
Sandip Institute of Pharmaceutical Sciences 1, Mahiravani, Nashik - 422213, Maharashtra, India.
Department of Pharmaceutical Chemistry 2, SSDJ College of Pharmacy Chandwad, Nashik - 423101, Maharashtra, India.
ABSTRACT: In the present investigation, the chalcone intermediates are synthesized by Claisen-Schmidt condensation reaction between acetanilide and appropriate aromatic aldehydes. Further, these chalcone intermediates were cyclized with phenylhydrazine in glacial acetic acid to give new pyrazolines derivatives using ultrasonic irradiation with higher yields in lesser time. All the synthesized derivatives are characterized by their TLC, Physical constant, FTIR, and 1H NMR. The Chalcone intermediates were screened for their antimicrobial activity while cyclized pyrazolines derivatives were screened in search of potential anti-inflammatory compounds. The compound 4c had shown good potential for anti-inflammatory activity.
Keywords: |
Ultrasound irradiation, Chalcone, Pyrazole, Anti-inflammatory activity
INTRODUCTION: Chalcones are α, β-unsaturated ketones which contain two aromatic groups and bridged by an enone linkage. They form the central core for a variety of important biological compounds. They are mainly intermediates in the synthesis of various biologically active compounds 1, 2. The modifications on the chalcone backbone result in the generation of various heterocyclic systems. The acetamido group containing compounds have been found as essential pharmacophore, and thus incorporation of these in chalcone backbone may result in compounds with significant activity 3, 4. When synthesized chalcones are subsequently cyclized with hydrazines, gives Pyrazolines 5, 6. Among Pyrazoles, 2-pyrazolines are widely used as useful synthons in organic synthesis and having various biological activities 7, 8.
Most of the synthetic methods for 2-pyrazolines suffer from several disadvantages such as long reaction times, expensive reagents, drastic reaction conditions, low yields, tedious workup procedures, and formation of byproducts. Nowadays, the application of Ultrasonic irradiation has aroused more and more interest in synthetic chemistry, which overcome the disadvantages and accelerates the reactivity millions fold and many synthetically useful reactions were accomplished 9-11.
Given this, the present investigation involves the synthesis of Pyrazoline derivatives through cyclization of synthesized chalcones having acetamido pharmacophore under ultrasonic irradiation in search of potential anti-inflammatory compounds 12-15.
MATERIALS AND METHODS: The starting materials and solvents used for each reaction are of synthetic grade procured from Sigma Aldrich. All the chemicals and synthesized products were characterized for their purity by physical constant and Thin Layer Chromatography (TLC). All the reactions were monitored by using thin layer chromatography on pre-coated TLC plates (Silica gel 60-120#) by using solvent system Benzene: Ethanol [8:2] for Step-1 compounds and Dichloromethane: Ethyl acetate [9:1] for Step-2 compounds. The obtained TLC plates were observed under a long UV lamp in a UV chamber and also in iodine chamber for detection of spots. All reactions were carried out ultrasonic irradiation by using sonicator made of Labman Scientific Instruments. The synthesized compounds were characterized by spectroscopic method FTIR and 1H NMR for elucidation and confirmation of their structures.
Synthesis Under Ultrasonic Irradiation:
Step I: Synthesis of Chalcones: Acetanilide (1, 1 mmole), dissolved with appropriate aromatic aldehydes (2, 1 mmole) in 95% of ethanol solvent (10 mL) and 2N sodium hydroxide (3 mL), taken into a 100 ml conical flask. The mixture was irradiated by an ultrasonic generator in a water-bath at 40-45 °C for 20 min. The reaction mixture so formed was diluted with water and neutralized with 2N hydrochloric acid. Collect the precipitate by filtration and washed well with cold water (2 × 20 mL). Further, recrystallization of crude product was carried out by using ethanol and collect the yellow crystals of chalcone 3a-e. Their physical characteristics data of these are reported in Table 1.
Step II: Synthesis of Pyrazolines: Synthesized chalcones 3a-e (1 mmole), phenylhydrazine, (2 mmoles) and glacial acetic acid (10 mL) were taken into a 100 mL conical flask. This reaction flask was suspended in the ultrasonic bath to get the ultrasound energy and sonicated until complete disappearance of chalcone. Further, the reaction mixture was poured into crushed ice and keep overnight. The obtained precipitate was collected by filtration and washed well with cold water (2 × 20 mL). Purification of crude product was carried out by recrystallization by using ethanol to give crystals of pyrazolines 4a-e. The products were characterized by IR and 1H NMR spectral data. The physical characteristics data of these are reported in Table 2.
The following sequence of reaction appears to afford a satisfactory explanation of the mode of formation of the products. This reaction involves the initial formation of aryl hydrazones with the subsequent attack of nitrogen upon the carbon-carbon double bond.
Reaction Scheme:
Biological Activity:
Antimicrobial Activity of Chalcone: The antibacterial activity of all the synthesized compounds 3a-e were screened against different gram‐positive (Staphylococcus aureus and Streptococcus pyogenes) and gram‐negative (Escherichia coli and Pseudomonas aeruginosa) bacteria by measuring zone of inhibition. The antibacterial activity was performed by Agar diffusion method at the concentration level of 50 μg/ml. Ciprofloxacin was used as a standard drug at a concentration of 50 μg/ml. Nutrient agar was used as culture media, and DMSO was used as solvent 16-18.
Anti-inflammatory Activity of Pyrazolines: The anti-inflammatory of the test compounds 4a-e was carried out using the carrageenan‑induced rat paw edema inhibition method. Acute inflammation was produced by subplantar injection of 0.1 ml of 1% suspension of carrageenan in the right hind paw of the rats, 30 min after oral administration of the drugs. The paw volume was measured plethysmometrically (IITC Digital Plethysmograph IITC‑520) at 1, 2, 3, and 4 h after the carrageenan injection. Ibuprofen was used as the standard drug at a dose level of 10 mg/kg. The percentage inhibition of edema was calculated using the formula 19, 20.
% Inhibition = (1−Vt/Vc) × 100
Where Vt is edema volume in treated groups, and Vc is edema volume in control groups.
RESULTS AND DISCUSSION: All chemicals and products have shown single spot on TLC plate when observed under UV light and iodine chamber. The melting points were taken in open capillaries on melting point apparatus and were found uncorrected.
TABLE 1: PHYSICAL CHARACTERISTICS DATA OF SYNTHESIZED CHALCONE INTERMEDIATES
Comp. No. | R | Temp. (ºC) | Time (Min.) | % Yield |
3a | -NO2 | 30 | 30 | 84 |
3b | -Cl | 25 | 40 | 81 |
3c | -F | 25 | 40 | 78 |
3d | -CH3 | 40 | 35 | 80 |
3e | -OH | 35 | 30 | 86 |
TABLE 2: PHYSICAL CHARACTERISTICS DATA OF SYNTHESIZED PYRAZOLINE DERIVATIVES
Comp. No. | R | Temp. (ºC) | Time (Min.) | % Yield |
4a | -NO2 | 35 | 40 | 77 |
4b | -Cl | 40 | 30 | 72 |
4c | -F | 40 | 35 | 69 |
4d | -CH3 | 35 | 40 | 75 |
4e | -OH | 40 | 30 | 70 |
Spectral Data: The Infrared spectroscopy was carried out by using potassium bromide (KBr) pellet method on the Shimadzu IR Affinity-1. The NMR spectra were recorded on Bruker Avance III 500 MHz multi-nuclei solution NMR spectrometer. The characterization with IR and 1H NMR spectra of the synthesized compounds confirmed the anticipated structure. The spectral data of synthesized pyrazolines has been shown in Table 3.
TABLE 3: SPECTRAL DATA OF SYNTHESIZED PYRAZOLINES
Compound 4a: 1,3-diphenyl-5-(4-nitrophenyl)-4,5-dihydro-1H-pyrazole: M.P: 146 ºC Rf: 0.8 | ||
IR (KBr cm-1) | : | 3211 (C–H), 1624 (C=N), 1332 (C–N), 1538(C=C), 1358 (NO2) |
Compound 4b: 1,3-diphenyl-5-(4-chloroophenyl)-4,5-dihydro-1H-pyrazole: M.P:182 ºC Rf: 0.7 | ||
IR (KBr cm-1)
1H NMR (δ ppm) |
:
: |
3216 (C–H), 1640 (C=N), 1326 (C–N), 1542 (C=C), 710 (C–Cl)
3.109 (dd, 1H), 3.814 (dd, 1H), 5.210 (dd, 1H), 6.912–7.808 (m, 12H, Ar–H) |
Compound 4c: 1,3-diphenyl-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazole: M.P:160 ºC Rf:0.6 | ||
IR (KBr cm-1)
1H NMR (δ ppm) |
:
: |
3248 (C–H), 1637 (C=N), 1328 (C–N), 1568 (C=C), 1212 (C–F)
3.126 (dd, 1H), 3.832 (dd, 1H),5.224 (dd, 1H), 6.908-7.823 (m, 12H, Ar–H) |
Compound 4d: 1,3-diphenyl-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazole: M.P:156 ºC Rf:0.8 | ||
IR (KBr cm-1) | : | 3256 (C–H), 1629 (C=N), 1364 (C–N), 1554 (C=C) |
Compound 4e:1,3-diphenyl-5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazole: M.P:134 ºC Rf:0.7 | ||
IR (KBr cm-1) | : | 3248 (C–H), 1637 (C=N), 1328 (C–N), 1568 (C=C), 3542 (OH) |
Biological Activity: Though we have many synthetic drugs in the market, the bacterial mutations are making them resistance. Given this, the synthesized intermediate compounds in the present investigation (3a-e) were evaluated for their antimicrobial activity.
Antimicrobial Activity of Chalcones: It is observed that the chalcone derivatives 3a-e showed antibacterial activity. From the result, It has been observed that the compound 3b and 3c showed good potential similar to the standard. In general, it is worth noting that compounds having fluorine and chlorine group in the scaffold exhibited excellent activity while the compounds having other substituent showed good to moderate activity. Antibacterial activity data (Zone of inhibition) of the synthesized chalcone derivatives 3a-e are presented in Table 4.
TABLE 4: ANTIMICROBIAL ACTIVITY OF COMPOUNDS 3a-e
Compound Code | Compound | Zone of inhibition (mm) | |||
Gram positive bacteria | Gram negative bacteria | ||||
S. aureus | S. pyogenes | E. coli | P. aeruginosa | ||
3a | NO2 | 8 | 10 | 12 | 14 |
3b | Cl | 9 | 10 | 13 | 14 |
3c | F | 10 | 11 | 15 | 17 |
3d | CH3 | 10 | 10 | 11 | 13 |
3e | OH | 9 | 10 | 13 | 15 |
Standard | Ciprofloxacin | 13 | 14 | 18 | 19 |
Solvent | DMSO | - | - | - | - |
Anti-inflammatory Activity of Pyrazolines: Assessment of anti-inflammatory action was completed via carrageenan‑induced rat paw edema inhibition method. The rate of edema hindrance was computed from the mean impact in control and treated creatures agreeing on the accompanying condition. Anti-inflammatory activity data of the synthesized Pyrazoline derivatives 4a-e are presented in Table 5.
TABLE 5: ANTI-INFLAMMATORY ACTIVITY OF PYRAZOLINES
Compound | Mean paw Oedema Volume (ml) ± SE | ||||||
0 hr | ½ h | 1h | 2 h | 3 h | 4 h | % inhibition after 4 h | |
Control | 0.122±0.0502 | 0.411±0.0749 | 2.14±0.163 | 2.84±0.279 | 2.60±0.318 | 1.42±0.314*** | -- |
Drug | 0.0826±0.0762 | 0.615±0.237 | 1.12±0.236 | 1.54±0.178 | 1.24±0.271 | 0.956±0.182*** | 51 |
4a | 0.124±0.0462 | 0.356±0.0823 | 1.55±0.432 | 1.86±0.139 | 1.42±0.326 | 1.29±0.243*** | 32 |
4b | 0.142±0.0514 | 0.339±0.0627 | 1.38±0.210 | 1.59±0.130 | 1.30±0.318 | 1.27±0.128*** | 36 |
4c | 0.110±0.0420 | 0.358±0.0524 | 1.43±0.136 | 1.58±0.216 | 1.42±0.114 | 1.26±0.135*** | 39 |
4d | 0.124±0.0414 | 0.255±0.129 | 1.39±0.182 | 1.67±0.232 | 1.34±0.428 | 1.26±0.224*** | 34 |
4e | 0.161±0.0429 | 0.242±0.109 | 1.78±0.136 | 1.52±0.249 | 1.41±0.132 | 1.21±0.132*** | 34 |
Values are expressed as mean ± SEM of six animals in each group. *Statistically significant (P≤0.05). **Statistically significant (P≤0.001)
CONCLUSION: Some of the new Pyrazoline derivatives were synthesized under ultrasonic irradiation and characterized by various analytical methods. These are successfully evaluated for their anti-inflammatory activity. Spectral data confirm the structure of the synthesized pyrazolines as expected. From the results, it can be concluded that the modified pyrazolines shows remarkable anti-inflammatory action and having the potential to study further.
ACKNOWLEDGEMENT: Nil
CONFLICT OF INTEREST: No conflict of interest.
REFERENCES:
- Sharma SP, Vashisht N and Kumar S: Ultrasound promoted green synthesis of chalcones of 3-acetyl-coumarin. Chemical Sci Transactions 2018; 7(3): 396-01.
- Al-ALshaikh MA: Ultrasound-assisted Heterocycles Synthesis. Res. J. Chem. Environ 2016; 20(9): 36-46.
- Raguraman A, Santhi N: Synthesis and characterization of 1,3,5-trisubstituted pyrazoline derivatives by ultrasonic irradiation method and evaluation of its antibacterial activity. International Letters of Chemistry, Physics and Astronomy 2014; 39: 219-33.
- Gupta R, Gupta N and Jain A: Improved synthesis of chalcones and pyrazolines under ultrasonic irradiation. Indian J. of Chemistry 2010; 49(B): 351-55.
- Cella R and Stefani HA: Ultrasound in Heterocycles Chemistry. Tetrahedron 2009; 65: 2619-41.
- Li JT, Yang WZ, Wang SX, Li SH and Li TS: Improved synthesis of chalcones under ultrasound irradiation. Ultrason Sonochem 2002; 9: 237-39.
- Bekhit AA, Hayam MA and Ashour AA: Novel pyrazole derivatives as a potential promising anti‐inflammatory, antimicrobial agents. Arch Pharma 2005; 338(4): 167-74.
- Elzupir AO: Ultrasound irradiation promoted the synthesis of chalcones, analogues, homologues and related furanyl containing compounds and their antibacterial activity. Int J Curr Pharm Res 2013; 5(4): 23-25.
- Panigrahi N, Ganguly S and Panda J: Ultrasound-assisted synthesis and antimicrobial evaluation of novel thiophene chalcone derivatives. Chemical Science Transactions 2014; 3(3): 1163-71.
- Shah PR, Phadke S and Borole P: Synthesis of new chalcone derivatives as antibacterial agents. Int. J. Pharm. Phytopharmacol. Res 2014; 4 (2): 95-99.
- Sharshira EM and Hamada NMM: Synthesis and antimicrobial evaluation of some pyrazole derivatives. Molecules 2012; 17: 4962-71.
- Ezhilarasi RM, Jayachandramani N and Mahalakshmi S: A Green chemical method for the synthesis of chalcones using Amberlite Resin. International Journal of Advanced Chemical Science and Applications 2015; 3: 1-5.
- Reddy SP, Donthamsetty V and Adivireddy P: Synthesis and antimicrobial activity of some new 3, 5-disubstituted pyrazoles and isoxazoles. Med Chem 2017; 7(12): 371-80.
- Verma AK, Alex M and Singh AK: Evaluation of anti-inflammatory and analgesic activity of novel pyrazole derivatives. Asian Journal of Biomedical and Pharmaceutical Sciences 2014; 4(37): 21-25.
- Trung HB: Design and synthesis of chalcone derivatives as potential non-purine xanthine oxidase inhibitors. Springer Plus 2016; 5: 1789.
- Singh P and Raj R: 1, 2, 3-Triazole tethered beta-lactam- Chalcone bifunctional hybrids: Synthesis and anticancer evaluation. European Journal of Medicinal Chemistry 2011; 30: 1-7.
- Manivannan C and Santhi N: Synthesis, characterization, molecular docking studies and antibacterial evaluation of chalcone based pyrazolines as DNA gyrase inhibitors. Int J Modn Res Revs 2015; 3(5): 679-87.
- El-Moghazy SM and Barsoum FF: Synthesis and anti-inflammatory activity of some pyrazole derivatives. Medicinal Chemistry Research 2012; 21: 1722-33.
- Mathew A, Mary STL, Arun KT and Radha K: Design, synthesis and biological evaluation of pyrazole analogues of natural piperine. Hygeia J D Med 2011; 3(2): 48-56.
- Rizk SA: Ultrasonic and Grinding aptitudes of one‐pot synthesis of 5‐ (4‐ Chlorophenyl)‐ 7‐ (3, 4‐ Dimethyl Phenyl)‐2‐oxo‐2H‐Pyrano[2,3‐b]Pyridine derivatives as antibacterial agents. J of heterocyclic chemistry 2017; 54(3): 2003-11.
How to cite this article:
Sethiya JP, Bhavsar SP and Shahare HV: Synthesis of potential anti-inflammatory pyrazoline derivatives under ultrasonic irradiation. Int J Pharm Sci & Res 2019; 10(7): 3290-94. doi: 10.13040/IJPSR.0975-8232.10(7).3290-94.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
18
3290-3294
664
985
English
IJPSR
J. P. Sethiya, S. P. Bhavsar and H. V. Shahare *
Department of Pharmaceutical Chemistry, SSDJ College of Pharmacy Chandwad, Nashik, Maharashtra, India.
hvshahare@gmail.com
03 November 2018
14 January 2019
18 January 2019
10.13040/IJPSR.0975-8232.10(7).3290-94
01 July 2019